HP
BHC icon

HealthInvest Partners’s Bausch Health BHC Stock Holding History

HealthInvest Partners’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-370,000
Closed -$9.73M – 20
2016
Q1 		$9.73M Buy
+370,000
New +$27.4M 4.56% 13

Other funds holding BHC

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthInvest Partners's BHC Position: Q2 2016 in Review

HealthInvest Partners sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 370,000 shares — an estimated $9.73M sold.

HealthInvest Partners first reported a position in BHC in Q1 2016 and held it in 1 quarter. The position peaked at $9.73M in Q1 2016. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

  • HealthInvest Partners reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
  • HealthInvest Partners sold 370,000 Bausch Health shares in Q2 2016, an estimated $9.73M.
  • HealthInvest Partners first reported a position in Bausch Health in Q1 2016 and held it in 1 quarter.
  • HealthInvest Partners's Bausch Health position peaked at $9.73M in Q1 2016.
  • 347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on HealthInvest Partners's 13F filing for Q2 2016, filed 26 Jul 2016.